Modeling temperature changes during HIPEC surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to develop and validate a computational thermodynamic model to predict temperature changes in patients undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for abdominal cancers. By collecting real-world data from patients, the study will incorporate various factors such as patient demographics, anesthetic methods, and circulatory impacts to understand temperature variations during the procedure. The goal is to enhance the safety and effectiveness of HIPEC by providing clinicians with better predictive tools for managing body temperatures during treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults (at least 18 years or older)
* Scheduled to undergo HIPEC surgery for abdominal cancer at HFH-Main

Exclusion Criteria:

* Pregnant females
* Minors
* Disease not amenable for treatment with HIPEC after surgical examination.

Where it's running

• Katherine Nowak
  Detroit, Michigan, United States Recruiting

Study contacts

• Principal investigator: Carlos Guerra, MD — Staff Anesthesiologist
• Study coordinator: Katherine Nowak, PhD
• Email: knowak2@hfhs.org
• Phone: 313-771-7128

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• HIPEC during curative gastrectomy for advanced or low‑volume metastatic gastric cancer

  This tests whether adding a single heated dose of chemotherapy inside the abdomen (HIPEC) during curative gastrectomy helps people with T4 tumors or low‑volume peritoneal gastric cancer.

  Recruiting Ukrainian Society of Clinical Oncology · Kyiv · NCT07313579

• Can Gleolan help highlight kidney tumors during partial nephrectomy?

  This study tests whether giving Gleolan before kidney surgery helps fluorescence identify cancer tissue in adults with suspected kidney cancer undergoing partial nephrectomy.

  Recruiting Phase 2 Henry Ford Health System · Detroit, Michigan · NCT07828704

• See how well ICG fluorescence can show knee tissue blood flow during arthroscopy

  This study tests whether injecting a dye called ICG can help doctors see blood flow in knee tissues during arthroscopic knee surgery, including different ACL tear severities.

  Recruiting Phase 1 Henry Ford Health System · Detroit, Michigan · NCT07793266

• Long-acting local pain medicine after knee replacement

  This study tests whether a new extended-release pain medicine (Zynrelef) given around the knee during total knee replacement can reduce pain after surgery better or as well as standard injections or nerve blocks.

  Recruiting Phase 4 Henry Ford Health System · Grosse Pointe Farms, Michigan · NCT07775248

• Can blood and physical tests before transplant predict non-relapse mortality

  This study tests whether pre-transplant blood markers and physical tests can predict non-relapse mortality in adults undergoing stem cell therapy.

  Recruiting Henry Ford Health System · Detroit, Michigan · NCT07769151

• Multimodal Pain Plan to Cut Opioids After Hip Replacement

  This study tests whether a multimodal pain regimen with a printed opioid prescription (instead of pharmacy-direct dispensing) can control pain after hip replacement while reducing opioid use.

  Recruiting Henry Ford Health System · Detroit, Michigan · NCT07672808

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.